8 research outputs found
ΠΠ΅ΡΡΠΏΠ΅ΠΊΡΠΈΠ²Π½ΡΠ΅ Π½Π°ΠΏΡΠ°Π²Π»Π΅Π½ΠΈΡ ΠΏΠΎΠ΄Π³ΠΎΡΠΎΠ²ΠΊΠΈ ΠΏΡΠΎΠ²ΠΈΠ·ΠΎΡΠΎΠ² Π΄Π»Ρ ΡΠΏΡΠ°Π²Π»Π΅Π½ΠΈΡ Π»Π΅ΠΊΠ°ΡΡΡΠ²Π΅Π½Π½ΠΎΠΉ ΠΏΠΎΠΌΠΎΡΡΡ Π² ΡΠΈΡΡΠ΅ΠΌΠ΅ Π·Π΄ΡΠ°Π²ΠΎΠΎΡ ΡΠ°Π½Π΅Π½ΠΈΡ
In clause the basic directions of perfection of vocational training and retraining of the pharmaceutical staff in modern conditions are considered and ways of optimization of a professional orientation of training of heads of the pharmaceutical organizations in the field of economy and managements are certain.Π ΡΡΠ°ΡΡΠ΅ ΡΠ°ΡΡΠΌΠΎΡΡΠ΅Π½Ρ ΠΎΡΠ½ΠΎΠ²Π½ΡΠ΅ Π½Π°ΠΏΡΠ°Π²Π»Π΅Π½ΠΈΡ ΡΠΎΠ²Π΅ΡΡΠ΅Π½ΡΡΠ²ΠΎΠ²Π°Π½ΠΈΡ ΠΏΡΠΎΡΠ΅ΡΡΠΈΠΎΠ½Π°Π»ΡΠ½ΠΎΠΉ ΠΏΠΎΠ΄Π³ΠΎΡΠΎΠ²ΠΊΠΈ ΠΈ ΠΏΠ΅ΡΠ΅ΠΏΠΎΠ΄Π³ΠΎΡΠΎΠ²ΠΊΠΈ ΡΠ°ΡΠΌΠ°ΡΠ΅Π²ΡΠΈΡΠ΅ΡΠΊΠΈΡ
ΠΊΠ°Π΄ΡΠΎΠ² Π² ΡΠΎΠ²ΡΠ΅ΠΌΠ΅Π½Π½ΡΡ
ΡΡΠ»ΠΎΠ²ΠΈΡΡ
ΠΈ ΠΎΠΏΡΠ΅Π΄Π΅Π»Π΅Π½Ρ ΠΏΡΡΠΈ ΠΎΠΏΡΠΈΠΌΠΈΠ·Π°ΡΠΈΠΈ ΠΏΡΠΎΡΠ΅ΡΡΠΈΠΎΠ½Π°Π»ΡΠ½ΠΎΠΉ Π½Π°ΠΏΡΠ°Π²Π»Π΅Π½Π½ΠΎΡΡΠΈ ΠΎΠ±ΡΡΠ΅Π½ΠΈΡ ΡΡΠΊΠΎΠ²ΠΎΠ΄ΠΈΡΠ΅Π»Π΅ΠΉ ΡΠ°ΡΠΌΠ°ΡΠ΅Π²ΡΠΈΡΠ΅ΡΠΊΠΈΡ
ΠΎΡΠ³Π°Π½ΠΈΠ·Π°ΡΠΈΠΉ Π² ΠΎΠ±Π»Π°ΡΡΠΈ ΡΠΊΠΎΠ½ΠΎΠΌΠΈΠΊΠΈ ΠΈ ΡΠΏΡΠ°Π²Π»Π΅Π½ΠΈΡ
ΠΡΠ³Π°Π½ΠΈΠ·Π°ΡΠΈΠΎΠ½Π½ΠΎ-ΡΠΊΠΎΠ½ΠΎΠΌΠΈΡΠ΅ΡΠΊΠΈΠΉ ΠΌΠ΅Ρ Π°Π½ΠΈΠ·ΠΌ ΡΠ°Π·Π²ΠΈΡΠΈΡ ΡΡΠ΅ΡΡ ΠΎΠ±ΡΠ°ΡΠ΅Π½ΠΈΡ Π»Π΅ΠΊΠ°ΡΡΡΠ²Π΅Π½Π½ΡΡ ΡΡΠ΅Π΄ΡΡΠ² Π² ΡΠ΅Π²Π΅ΡΠ½ΡΡ ΠΈ Π°ΡΠΊΡΠΈΡΠ΅ΡΠΊΠΈΡ ΡΠ΅ΡΡΠΈΡΠΎΡΠΈΡΡ
A SWOT-analysis of the drug regulation sphere was conducted in the northern and Arctic regions of the Republic of Sakha (Yakutia). The analysis made it possible to identify the strengths and weaknesses, opportunities and threats of this sphere and justify the need to develop an organizational and economic mechanism for its development. The scientific novelty of the research lies in the development of a conceptual framework for the organizational and economic mechanism of the development of the drug regulation sphere in the region that has northern and Arctic territories.ΠΡΠΎΠ²Π΅Π΄Π΅Π½ SWOT-Π°Π½Π°Π»ΠΈΠ· ΡΡΠ΅ΡΡ ΠΎΠ±ΡΠ°ΡΠ΅Π½ΠΈΡ Π»Π΅ΠΊΠ°ΡΡΡΠ²Π΅Π½Π½ΡΡ
ΡΡΠ΅Π΄ΡΡΠ² Π² ΡΠ΅Π²Π΅ΡΠ½ΡΡ
ΠΈ Π°ΡΠΊΡΠΈΡΠ΅ΡΠΊΠΈΡ
ΡΠ°ΠΉΠΎΠ½Π°Ρ
Π Π΅ΡΠΏΡΠ±Π»ΠΈΠΊΠΈ Π‘Π°Ρ
Π° (Π―ΠΊΡΡΠΈΡ), Π²ΡΡΠ²Π»Π΅Π½Ρ ΡΠΈΠ»ΡΠ½ΡΠ΅ ΠΈ ΡΠ»Π°Π±ΡΠ΅ ΡΡΠΎΡΠΎΠ½Ρ ΡΡΠΎΠΉ ΡΡΠ΅ΡΡ, Π΅Π΅ Π²ΠΎΠ·ΠΌΠΎΠΆΠ½ΠΎΡΡΠΈ ΠΈ ΡΠ³ΡΠΎΠ·Ρ, ΠΎΠ±ΠΎΡΠ½ΠΎΠ²Π°Π½Π° Π½Π΅ΠΎΠ±Ρ
ΠΎΠ΄ΠΈΠΌΠΎΡΡΡ ΡΠ°Π·ΡΠ°Π±ΠΎΡΠΊΠΈ ΠΎΡΠ³Π°Π½ΠΈΠ·Π°ΡΠΈΠΎΠ½Π½ΠΎ-ΡΠΊΠΎΠ½ΠΎΠΌΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ ΠΌΠ΅Ρ
Π°Π½ΠΈΠ·ΠΌΠ° Π΅Π΅ ΡΠ°Π·Π²ΠΈΡΠΈΡ. ΠΠ°ΡΡΠ½Π°Ρ Π½ΠΎΠ²ΠΈΠ·Π½Π° ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡ Π·Π°ΠΊΠ»ΡΡΠ°Π΅ΡΡΡ Π² ΡΠ°Π·ΡΠ°Π±ΠΎΡΠΊΠ΅ ΠΊΠΎΠ½ΡΠ΅ΠΏΡΡΠ°Π»ΡΠ½ΡΡ
ΠΎΡΠ½ΠΎΠ² ΠΎΡΠ³Π°Π½ΠΈΠ·Π°ΡΠΈΠΎΠ½Π½ΠΎ-ΡΠΊΠΎΠ½ΠΎΠΌΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ ΠΌΠ΅Ρ
Π°Π½ΠΈΠ·ΠΌΠ° ΡΠ°Π·Π²ΠΈΡΠΈΡ ΡΡΠ΅ΡΡ ΠΎΠ±ΡΠ°ΡΠ΅Π½ΠΈΡ Π»Π΅ΠΊΠ°ΡΡΡΠ²Π΅Π½Π½ΡΡ
ΡΡΠ΅Π΄ΡΡΠ² Π² ΡΠ΅Π³ΠΈΠΎΠ½Π΅, ΠΈΠΌΠ΅ΡΡΠ΅ΠΌ ΡΠ΅Π²Π΅ΡΠ½ΡΠ΅ ΠΈ Π°ΡΠΊΡΠΈΡΠ΅ΡΠΊΠΈΠ΅ ΡΠ΅ΡΡΠΈΡΠΎΡΠΈΠΈ
ΠΠ ΠΠΠΠΠΠ« ΠΠΠ’ΠΠ§ΠΠΠΠ ΠΠΠΠΠ’ΠΠΠΠΠΠΠ― ΠΠΠΠΠ Π‘Π’ΠΠΠΠΠ«Π₯ ΠΠ ΠΠΠΠ ΠΠ’ΠΠ
The research explorers the main problems arising in the manufacture of dosage forms. A sociological survey of medical and pharmaceutical workers has been conducted. The statistical model of the range of extemporaneous medicines for confirmation of need of further improvement of a type of activity of the pharmaceutical organization as production of medicines has been created. The significance level of the sample of dosage forms produced in pharmacies has been calculated. The results of calculations showed that the range of pharmaceutical products has statistically significant differences. The value of the confidence interval of the difference in proportions indicates that the need of the population and medical organizations in medicines can not be provided only at the expense of finished pharmaceutical products of industrial manufacture.Π Π°ΡΡΠΌΠΎΡΡΠ΅Π½Ρ ΠΎΡΠ½ΠΎΠ²Π½ΡΠ΅ ΠΏΡΠΎΠ±Π»Π΅ΠΌΡ, Π²ΠΎΠ·Π½ΠΈΠΊΠ°ΡΡΠΈΠ΅ ΠΏΡΠΈ ΠΈΠ·Π³ΠΎΡΠΎΠ²Π»Π΅Π½ΠΈΠΈ Π»Π΅ΠΊΠ°ΡΡΡΠ²Π΅Π½Π½ΡΡ
ΡΠΎΡΠΌ Π² Π°ΠΏΡΠ΅ΠΊΠ°Ρ
. ΠΡΠΎΠ²Π΅Π΄Π΅Π½ ΡΠΎΡΠΈΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΈΠΉ ΠΎΠΏΡΠΎΡ ΠΌΠ΅Π΄ΠΈΡΠΈΠ½ΡΠΊΠΈΡ
ΠΈ ΡΠ°ΡΠΌΠ°ΡΠ΅Π²ΡΠΈΡΠ΅ΡΠΊΠΈΡ
ΡΠ°Π±ΠΎΡΠ½ΠΈΠΊΠΎΠ². Π‘ΡΠΎΡΠΌΠΈΡΠΎΠ²Π°Π½Π° ΡΡΠ°ΡΠΈΡΡΠΈΡΠ΅ΡΠΊΠ°Ρ ΠΌΠΎΠ΄Π΅Π»Ρ Π°ΡΡΠΎΡΡΠΈΠΌΠ΅Π½ΡΠ° ΡΠΊΡΡΠ΅ΠΌΠΏΠΎΡΠ°Π»ΡΠ½ΡΡ
Π»Π΅ΠΊΠ°ΡΡΡΠ²Π΅Π½Π½ΡΡ
ΠΏΡΠ΅ΠΏΠ°ΡΠ°ΡΠΎΠ² Π΄Π»Ρ ΠΏΠΎΠ΄ΡΠ²Π΅ΡΠΆΠ΄Π΅Π½ΠΈΡ Π½Π΅ΠΎΠ±Ρ
ΠΎΠ΄ΠΈΠΌΠΎΡΡΠΈ Π΄Π°Π»ΡΠ½Π΅ΠΉΡΠ΅Π³ΠΎ ΡΠΎΠ²Π΅ΡΡΠ΅Π½ΡΡΠ²ΠΎΠ²Π°Π½ΠΈΡ ΡΠ°ΠΊΠΎΠ³ΠΎ Π²ΠΈΠ΄Π° Π΄Π΅ΡΡΠ΅Π»ΡΠ½ΠΎΡΡΠΈ Π°ΠΏΡΠ΅ΡΠ½ΠΎΠΉ ΠΎΡΠ³Π°Π½ΠΈΠ·Π°ΡΠΈΠΈ, ΠΊΠ°ΠΊ ΠΈΠ·Π³ΠΎΡΠΎΠ²Π»Π΅Π½ΠΈΠ΅ Π»Π΅ΠΊΠ°ΡΡΡΠ²Π΅Π½Π½ΡΡ
ΠΏΡΠ΅ΠΏΠ°ΡΠ°ΡΠΎΠ². ΠΡΡΠΈΡΠ»Π΅Π½ ΡΡΠΎΠ²Π΅Π½Ρ Π·Π½Π°ΡΠΈΠΌΠΎΡΡΠΈ (significance level) Π²ΡΠ±ΠΎΡΠΊΠΈ Π»Π΅ΠΊΠ°ΡΡΡΠ²Π΅Π½Π½ΡΡ
ΡΠΎΡΠΌ, ΠΈΠ·Π³ΠΎΡΠΎΠ²Π»ΡΠ΅ΠΌΡΡ
Π² Π°ΠΏΡΠ΅ΠΊΠ°Ρ
. Π Π΅Π·ΡΠ»ΡΡΠ°ΡΡ Π²ΡΡΠΈΡΠ»Π΅Π½ΠΈΠΉ ΠΏΠΎΠΊΠ°Π·Π°Π»ΠΈ, ΡΡΠΎ Π°ΡΡΠΎΡΡΠΈΠΌΠ΅Π½Ρ Π»Π΅ΠΊΠ°ΡΡΡΠ²Π΅Π½Π½ΡΡ
ΠΏΡΠ΅ΠΏΠ°ΡΠ°ΡΠΎΠ² Π°ΠΏΡΠ΅ΡΠ½ΠΎΠ³ΠΎ ΠΏΡΠΎΠΈΠ·Π²ΠΎΠ΄ΡΡΠ²Π° ΠΈΠΌΠ΅Π΅Ρ ΡΡΠ°ΡΠΈΡΡΠΈΡΠ΅ΡΠΊΠΈ Π·Π½Π°ΡΠΈΠΌΡΠ΅ ΡΠ°Π·Π»ΠΈΡΠΈΡ. ΠΠ½Π°ΡΠ΅Π½ΠΈΠ΅ Π΄ΠΎΠ²Π΅ΡΠΈΡΠ΅Π»ΡΠ½ΠΎΠ³ΠΎ ΠΈΠ½ΡΠ΅ΡΠ²Π°Π»Π° ΡΠ°Π·Π½ΠΈΡΡ ΠΏΡΠΎΠΏΠΎΡΡΠΈΠΉ ΡΠ²ΠΈΠ΄Π΅ΡΠ΅Π»ΡΡΡΠ²ΡΠ΅Ρ ΠΎ ΡΠΎΠΌ, ΡΡΠΎ ΠΏΠΎΡΡΠ΅Π±Π½ΠΎΡΡΡ Π½Π°ΡΠ΅Π»Π΅Π½ΠΈΡ ΠΈ ΠΌΠ΅Π΄ΠΈΡΠΈΠ½ΡΠΊΠΈΡ
ΠΎΡΠ³Π°Π½ΠΈΠ·Π°ΡΠΈΠΉ Π² Π»Π΅ΠΊΠ°ΡΡΡΠ²Π΅Π½Π½ΡΡ
ΠΏΡΠ΅ΠΏΠ°ΡΠ°ΡΠ°Ρ
Π½Π΅ ΠΌΠΎΠΆΠ΅Ρ Π±ΡΡΡ ΠΎΠ±Π΅ΡΠΏΠ΅ΡΠ΅Π½Π° ΡΠΎΠ»ΡΠΊΠΎ Π·Π° ΡΡΠ΅Ρ Π³ΠΎΡΠΎΠ²ΡΡ
Π»Π΅ΠΊΠ°ΡΡΡΠ²Π΅Π½Π½ΡΡ
ΠΏΡΠ΅ΠΏΠ°ΡΠ°ΡΠΎΠ² ΠΏΡΠΎΠΌΡΡΠ»Π΅Π½Π½ΠΎΠ³ΠΎ ΠΏΡΠΎΠΈΠ·Π²ΠΎΠ΄ΡΡΠ²Π°
ΠΠ»Π°ΡΡΠΈΡΠΈΠΊΠ°ΡΠΈΡ ΠΌΡΠ½ΠΈΡΠΈΠΏΠ°Π»ΡΠ½ΡΡ ΡΠ°ΠΉΠΎΠ½ΠΎΠ² Π Π΅ΡΠΏΡΠ±Π»ΠΈΠΊΠΈ Π‘Π°Ρ Π° (Π―ΠΊΡΡΠΈΡ) ΠΏΠΎ ΡΡΠΎΠ²Π½Ρ ΠΎΠΊΠ°Π·Π°Π½ΠΈΡ ΡΠ°ΡΠΌΠ°ΡΠ΅Π²ΡΠΈΡΠ΅ΡΠΊΠΎΠΉ ΠΏΠΎΠΌΠΎΡΠΈ Ρ ΠΈΡΠΏΠΎΠ»ΡΠ·ΠΎΠ²Π°Π½ΠΈΠ΅ΠΌ ΠΌΠ°ΡΠ΅ΠΌΠ°ΡΠΈΡΠ΅ΡΠΊΠΈΡ ΠΌΠ΅ΡΠΎΠ΄ΠΎΠ²
The authors used a cluster analysis for classification of the Republic of Sakha (Yakutia) municipal districts by level of management of pharmaceutical aid provided to the population. They substantiated the practical necessity of using the classification tools at the regional level for a subsequent assessment of the availability of pharmaceutical aid. Five indicators characterizing the socio-economic development of the regions and the state of medical and pharmaceutical aid in them were selected as classification criteria based on logical grounds. The cluster analysis and mathematical models showed the existing intra-regional disproportion in the development of the pharmaceutical service. The differences in the level of development of the pharmaceutical service were analysed using absolute indicators that determine the possibility of obtaining pharmaceutical aid in the formed clusters. A block diagram of the analysis of the availability of pharmaceutical aid in the Republic of Sakha (Yakutia) has been developed. The clustering results are recommended to be used to substantiate the strategy for development of the pharmaceutical service in the Republic of Sakha (Yakutia) and to develop an optimal model for ensuring the availability of pharmaceutical aid using socially oriented technologies.ΠΡΠΈΠΌΠ΅Π½Π΅Π½ ΠΊΠ»Π°ΡΡΠ΅ΡΠ½ΡΠΉ Π°Π½Π°Π»ΠΈΠ· Π΄Π»Ρ ΠΊΠ»Π°ΡΡΠΈΡΠΈΠΊΠ°ΡΠΈΠΈ ΠΌΡΠ½ΠΈΡΠΈΠΏΠ°Π»ΡΠ½ΡΡ
ΡΠ°ΠΉΠΎΠ½ΠΎΠ² Π Π΅ΡΠΏΡΠ±Π»ΠΈΠΊΠΈ Π‘Π°Ρ
Π° (Π―ΠΊΡΡΠΈΡ) ΠΏΠΎ ΡΡΠΎΠ²Π½Ρ ΠΎΡΠ³Π°Π½ΠΈΠ·Π°ΡΠΈΠΈ ΡΠ°ΡΠΌΠ°ΡΠ΅Π²ΡΠΈΡΠ΅ΡΠΊΠΎΠΉ ΠΏΠΎΠΌΠΎΡΠΈ Π½Π°ΡΠ΅Π»Π΅Π½ΠΈΡ. ΠΠ±ΠΎΡΠ½ΠΎΠ²Π°Π½Π° ΠΏΡΠ°ΠΊΡΠΈΡΠ΅ΡΠΊΠ°Ρ Π½Π΅ΠΎΠ±Ρ
ΠΎΠ΄ΠΈΠΌΠΎΡΡΡ ΠΈΡΠΏΠΎΠ»ΡΠ·ΠΎΠ²Π°Π½ΠΈΡ ΠΈΠ½ΡΡΡΡΠΌΠ΅Π½ΡΠ°ΡΠΈΡ ΠΊΠ»Π°ΡΡΠΈΡΠΈΠΊΠ°ΡΠΈΠΈ Π½Π° ΡΠ΅Π³ΠΈΠΎΠ½Π°Π»ΡΠ½ΠΎΠΌ ΡΡΠΎΠ²Π½Π΅ Π΄Π»Ρ ΠΏΠΎΡΠ»Π΅Π΄ΡΡΡΠ΅ΠΉ ΠΎΡΠ΅Π½ΠΊΠΈ Π΄ΠΎΡΡΡΠΏΠ½ΠΎΡΡΠΈ Π»Π΅ΠΊΠ°ΡΡΡΠ²Π΅Π½Π½ΠΎΠΉ ΠΏΠΎΠΌΠΎΡΠΈ. Π ΠΊΠ°ΡΠ΅ΡΡΠ²Π΅ ΠΊΡΠΈΡΠ΅ΡΠΈΠ΅Π² ΠΊΠ»Π°ΡΡΠΈΡΠΈΠΊΠ°ΡΠΈΠΈ Π»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΈΠΌ ΠΏΡΡΠ΅ΠΌ ΠΎΡΠΎΠ±ΡΠ°Π½Ρ 5 ΠΏΠΎΠΊΠ°Π·Π°ΡΠ΅Π»Π΅ΠΉ, Ρ
Π°ΡΠ°ΠΊΡΠ΅ΡΠΈΠ·ΡΡΡΠΈΡ
ΡΠΎΡΠΈΠ°Π»ΡΠ½ΠΎ-ΡΠΊΠΎΠ½ΠΎΠΌΠΈΡΠ΅ΡΠΊΠΎΠ΅ ΡΠ°Π·Π²ΠΈΡΠΈΠ΅ ΡΠ°ΠΉΠΎΠ½ΠΎΠ² ΠΈ ΡΠΎΡΡΠΎΡΠ½ΠΈΠ΅ Π² Π½ΠΈΡ
ΠΌΠ΅Π΄ΠΈΡΠΈΠ½ΡΠΊΠΎΠΉ ΠΈ ΡΠ°ΡΠΌΠ°ΡΠ΅Π²ΡΠΈΡΠ΅ΡΠΊΠΎΠΉ ΠΏΠΎΠΌΠΎΡΠΈ. Π Π΅Π·ΡΠ»ΡΡΠ°ΡΡ ΠΊΠ»Π°ΡΡΠ΅ΡΠ½ΠΎΠ³ΠΎ Π°Π½Π°Π»ΠΈΠ·Π° ΠΈ ΠΌΠ°ΡΠ΅ΠΌΠ°ΡΠΈΡΠ΅ΡΠΊΠΈΠ΅ ΠΌΠΎΠ΄Π΅Π»ΠΈ ΡΠ²ΠΈΠ΄Π΅ΡΠ΅Π»ΡΡΡΠ²ΡΡΡ ΠΎΠ± ΠΈΠΌΠ΅ΡΡΠ΅ΠΉΡΡ Π²Π½ΡΡΡΠΈΡΠ΅Π³ΠΈΠΎΠ½Π°Π»ΡΠ½ΠΎΠΉ Π΄ΠΈΡΠΏΡΠΎΠΏΠΎΡΡΠΈΠΈ Π² ΡΠ°Π·Π²ΠΈΡΠΈΠΈ ΡΠ°ΡΠΌΠ°ΡΠ΅Π²ΡΠΈΡΠ΅ΡΠΊΠΎΠΉ ΡΠ»ΡΠΆΠ±Ρ. ΠΠ½Π°Π»ΠΈΠ· ΡΠ°Π·Π»ΠΈΡΠΈΠΉ Π² ΡΡΠΎΠ²Π½Π΅ ΡΠ°Π·Π²ΠΈΡΠΈΡ ΡΠ°ΡΠΌΠ°ΡΠ΅Π²ΡΠΈΡΠ΅ΡΠΊΠΎΠΉ ΡΠ»ΡΠΆΠ±Ρ ΠΎΡΡΡΠ΅ΡΡΠ²Π»Π΅Π½ Ρ ΠΏΠΎΠΌΠΎΡΡΡ Π°Π±ΡΠΎΠ»ΡΡΠ½ΡΡ
ΠΏΠΎΠΊΠ°Π·Π°ΡΠ΅Π»Π΅ΠΉ, ΠΎΠΏΡΠ΅Π΄Π΅Π»ΡΡΡΠΈΡ
Π²ΠΎΠ·ΠΌΠΎΠΆΠ½ΠΎΡΡΡ ΠΏΠΎΠ»ΡΡΠ΅Π½ΠΈΡ ΡΠ°ΡΠΌΠ°ΡΠ΅Π²ΡΠΈΡΠ΅ΡΠΊΠΎΠΉ ΠΏΠΎΠΌΠΎΡΠΈ Π² ΡΡΠΎΡΠΌΠΈΡΠΎΠ²Π°Π½Π½ΡΡ
ΠΊΠ»Π°ΡΡΠ΅ΡΠ°Ρ
. Π Π°Π·ΡΠ°Π±ΠΎΡΠ°Π½Π° Π±Π»ΠΎΠΊ-ΡΡ
Π΅ΠΌΠ° Π°Π½Π°Π»ΠΈΠ·Π° Π΄ΠΎΡΡΡΠΏΠ½ΠΎΡΡΠΈ ΡΠ°ΡΠΌΠ°ΡΠ΅Π²ΡΠΈΡΠ΅ΡΠΊΠΎΠΉ ΠΏΠΎΠΌΠΎΡΠΈ Π² Π Π΅ΡΠΏΡΠ±Π»ΠΈΠΊΠ΅ Π‘Π°Ρ
Π° (Π―ΠΊΡΡΠΈΡ). Π Π΅ΠΊΠΎΠΌΠ΅Π½Π΄ΠΎΠ²Π°Π½ΠΎ ΠΈΡΠΏΠΎΠ»ΡΠ·ΠΎΠ²Π°Π½ΠΈΠ΅ ΡΠ΅Π·ΡΠ»ΡΡΠ°ΡΠΎΠ² ΠΊΠ»Π°ΡΡΠ΅ΡΠΈΠ·Π°ΡΠΈΠΈ Π΄Π»Ρ ΠΎΠ±ΠΎΡΠ½ΠΎΠ²Π°Π½ΠΈΡ ΡΡΡΠ°ΡΠ΅Π³ΠΈΠΈ ΡΠ°Π·Π²ΠΈΡΠΈΡ ΡΠ°ΡΠΌΠ°ΡΠ΅Π²ΡΠΈΡΠ΅ΡΠΊΠΎΠΉ ΡΠ»ΡΠΆΠ±Ρ Π Π΅ΡΠΏΡΠ±Π»ΠΈΠΊΠΈ Π‘Π°Ρ
Π° (Π―ΠΊΡΡΠΈΡ) ΠΈ ΡΠ°Π·ΡΠ°Π±ΠΎΡΠΊΠΈ ΠΎΠΏΡΠΈΠΌΠ°Π»ΡΠ½ΠΎΠΉ ΠΌΠΎΠ΄Π΅Π»ΠΈ ΠΎΠ±Π΅ΡΠΏΠ΅ΡΠ΅Π½ΠΈΡ Π΄ΠΎΡΡΡΠΏΠ½ΠΎΡΡΠΈ Π»Π΅ΠΊΠ°ΡΡΡΠ²Π΅Π½Π½ΠΎΠΉ ΠΏΠΎΠΌΠΎΡΠΈ Ρ ΠΈΡΠΏΠΎΠ»ΡΠ·ΠΎΠ²Π°Π½ΠΈΠ΅ΠΌ ΡΠΎΡΠΈΠ°Π»ΡΠ½ΠΎ ΠΎΡΠΈΠ΅Π½ΡΠΈΡΠΎΠ²Π°Π½Π½ΡΡ
ΡΠ΅Ρ
Π½ΠΎΠ»ΠΎΠ³ΠΈΠΉ
ΠΠ΅ΡΠΎΠ΄ΠΈΡΠ΅ΡΠΊΠΈΠ΅ ΠΏΠΎΠ΄Ρ ΠΎΠ΄Ρ ΠΊ ΡΠ°Π·ΡΠ°Π±ΠΎΡΠΊΠ΅ ΡΡΡΡΠΊΡΡΡΠ½ΠΎ-Π»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΎΠΉ ΡΡ Π΅ΠΌΡ ΠΏΠ΅ΡΡΠΎΠ½Π°Π»ΠΈΠ·ΠΈΡΠΎΠ²Π°Π½Π½ΠΎΠ³ΠΎ ΠΏΠΎΠ΄Π±ΠΎΡΠ° Π»Π΅ΠΊΠ°ΡΡΡΠ²Π΅Π½Π½ΡΡ ΠΏΡΠ΅ΠΏΠ°ΡΠ°ΡΠΎΠ² Π΄Π»Ρ ΠΎΠ½ΠΊΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΈΡ Π±ΠΎΠ»ΡΠ½ΡΡ
The article investigated the issues of the arrangement of personalized selection of drugs for cancer patients. The potential economic efficiency of the use of molecular genetic studies for the prescription of drugs and the cost-effectiveness was calculated using antitumor drugs as an example. A sociological survey of medical professionals on personalized selection of drugs in medical practice was conducted. A statistical link has been established between the practice of prescribing drugs according to the pharmacogenetic testing results and such indicators as side effects monitoring, pharmacoeconomic analysis of the use of drugs in medical organizations. The structural-logical scheme of interaction between the subjects of healthcare and the drug provision system for personalized therapeutic drug management for cancer patients has been developed based on scientific research.ΠΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½Ρ Π²ΠΎΠΏΡΠΎΡΡ ΠΎΡΠ³Π°Π½ΠΈΠ·Π°ΡΠΈΠΈ ΠΈΠ½Π΄ΠΈΠ²ΠΈΠ΄ΡΠ°Π»ΡΠ½ΠΎΠ³ΠΎ ΠΏΠΎΠ΄Π±ΠΎΡΠ° Π»Π΅ΠΊΠ°ΡΡΡΠ²Π΅Π½Π½ΡΡ
ΠΏΡΠ΅ΠΏΠ°ΡΠ°ΡΠΎΠ² Π΄Π»Ρ ΠΎΠ½ΠΊΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΈΡ
Π±ΠΎΠ»ΡΠ½ΡΡ
. Π Π°ΡΡΡΠΈΡΠ°Π½Ρ ΠΏΠΎΡΠ΅Π½ΡΠΈΠ°Π»ΡΠ½Π°Ρ ΡΠΊΠΎΠ½ΠΎΠΌΠΈΡΠ΅ΡΠΊΠ°Ρ ΡΡΡΠ΅ΠΊΡΠΈΠ²Π½ΠΎΡΡΡ ΠΏΡΠΈΠΌΠ΅Π½Π΅Π½ΠΈΡ ΠΌΠΎΠ»Π΅ΠΊΡΠ»ΡΡΠ½ΠΎ-Π³Π΅Π½Π΅ΡΠΈΡΠ΅ΡΠΊΠΈΡ
ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΠΉ ΠΏΡΠΈ Π½Π°Π·Π½Π°ΡΠ΅Π½ΠΈΠΈ Π»Π΅ΠΊΠ°ΡΡΡΠ²Π΅Π½Π½ΡΡ
ΠΏΡΠ΅ΠΏΠ°ΡΠ°ΡΠΎΠ² ΠΈ ΡΡΡΠ΅ΠΊΡΠΈΠ²Π½ΠΎΡΡΡ Π·Π°ΡΡΠ°Ρ Π½Π° ΠΏΡΠΈΠΌΠ΅ΡΠ΅ ΠΏΡΠΎΡΠΈΠ²ΠΎΠΎΠΏΡΡ
ΠΎΠ»Π΅Π²ΡΡ
ΠΏΡΠ΅ΠΏΠ°ΡΠ°ΡΠΎΠ². ΠΡΠΎΠ²Π΅Π΄Π΅Π½ ΡΠΎΡΠΈΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΈΠΉ ΠΎΠΏΡΠΎΡ ΠΌΠ΅Π΄ΠΈΡΠΈΠ½ΡΠΊΠΈΡ
ΡΠ°Π±ΠΎΡΠ½ΠΈΠΊΠΎΠ² ΠΏΠΎ Π²ΠΎΠΏΡΠΎΡΠ°ΠΌ ΠΏΠ΅ΡΡΠΎΠ½Π°Π»ΠΈΠ·ΠΈΡΠΎΠ²Π°Π½Π½ΠΎΠ³ΠΎ ΠΏΠΎΠ΄Π±ΠΎΡΠ° Π»Π΅ΠΊΠ°ΡΡΡΠ²Π΅Π½Π½ΡΡ
ΡΡΠ΅Π΄ΡΡΠ² Π² ΠΌΠ΅Π΄ΠΈΡΠΈΠ½ΡΠΊΠΎΠΉ ΠΏΡΠ°ΠΊΡΠΈΠΊΠ΅. Π£ΡΡΠ°Π½ΠΎΠ²Π»Π΅Π½Π° ΡΡΠ°ΡΠΈΡΡΠΈΡΠ΅ΡΠΊΠ°Ρ ΡΠ²ΡΠ·Ρ ΠΌΠ΅ΠΆΠ΄Ρ ΠΏΡΠ°ΠΊΡΠΈΠΊΠΎΠΉ Π½Π°Π·Π½Π°ΡΠ΅Π½ΠΈΡ Π»Π΅ΠΊΠ°ΡΡΡΠ²Π΅Π½Π½ΡΡ
ΠΏΡΠ΅ΠΏΠ°ΡΠ°ΡΠΎΠ² ΠΏΠΎ ΡΠ΅Π·ΡΠ»ΡΡΠ°ΡΠ°ΠΌ ΡΠ°ΡΠΌΠ°ΠΊΠΎΠ³Π΅Π½Π΅ΡΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ ΡΠ΅ΡΡΠΈΡΠΎΠ²Π°Π½ΠΈΡ ΠΈ ΡΠ°ΠΊΠΈΠΌΠΈ ΠΏΠΎΠΊΠ°Π·Π°ΡΠ΅Π»ΡΠΌΠΈ, ΠΊΠ°ΠΊ ΠΏΡΠΎΠ²Π΅Π΄Π΅Π½ΠΈΠ΅ ΠΌΠΎΠ½ΠΈΡΠΎΡΠΈΠ½Π³Π° ΠΏΠΎΠ±ΠΎΡΠ½ΡΡ
ΡΡΡΠ΅ΠΊΡΠΎΠ², ΡΠ°ΡΠΌΠ°ΠΊΠΎΡΠΊΠΎΠ½ΠΎΠΌΠΈΡΠ΅ΡΠΊΠΈΠΉ Π°Π½Π°Π»ΠΈΠ· ΠΏΡΠΈΠΌΠ΅Π½Π΅Π½ΠΈΡ Π»Π΅ΠΊΠ°ΡΡΡΠ²Π΅Π½Π½ΡΡ
ΡΡΠ΅Π΄ΡΡΠ² Π² ΠΌΠ΅Π΄ΠΈΡΠΈΠ½ΡΠΊΠΈΡ
ΠΎΡΠ³Π°Π½ΠΈΠ·Π°ΡΠΈΡΡ
. ΠΠ° ΠΎΡΠ½ΠΎΠ²Π΅ ΡΠ΅Π·ΡΠ»ΡΡΠ°ΡΠΎΠ² ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡ ΡΠ°Π·ΡΠ°Π±ΠΎΡΠ°Π½Π° ΡΡΡΡΠΊΡΡΡΠ½ΠΎ-Π»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠ°Ρ ΡΡ
Π΅ΠΌΠ° Π²Π·Π°ΠΈΠΌΠΎΠ΄Π΅ΠΉΡΡΠ²ΠΈΡ ΠΌΠ΅ΠΆΠ΄Ρ ΡΡΠ±ΡΠ΅ΠΊΡΠ°ΠΌΠΈ Π·Π΄ΡΠ°Π²ΠΎΠΎΡ
ΡΠ°Π½Π΅Π½ΠΈΡ ΠΈ ΡΠΈΡΡΠ΅ΠΌΠΎΠΉ Π»Π΅ΠΊΠ°ΡΡΡΠ²Π΅Π½Π½ΠΎΠ³ΠΎ ΠΎΠ±Π΅ΡΠΏΠ΅ΡΠ΅Π½ΠΈΡ ΠΏΡΠΈ ΠΏΠ΅ΡΡΠΎΠ½Π°Π»ΠΈΠ·ΠΈΡΠΎΠ²Π°Π½Π½ΠΎΠΌ ΠΏΠΎΠ΄Π±ΠΎΡΠ΅ Π»Π΅ΠΊΠ°ΡΡΡΠ²Π΅Π½Π½ΡΡ
ΠΏΡΠ΅ΠΏΠ°ΡΠ°ΡΠΎΠ² Π΄Π»Ρ Π»Π΅ΡΠ΅Π½ΠΈΡ ΠΎΠ½ΠΊΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΈΡ
Π±ΠΎΠ»ΡΠ½ΡΡ
Ways to improve the efficiency of pharmaceutical care in the treatment of tuberculosis
The article is devoted to generalization of the ways to optimize the consumption of antibacterial and anti-tuberculosis drugs in tuberculosis. The effectiveness of pharmaceutical treatment for tuberculosis in legal, organizational, and financial aspects is analyzed. Identified bottlenecks, the removal of which will allow you to optimize medicinal assistance to persons suffering from tuberculosis, to improve the effectiveness of spending financial means of the Federal budget and the quality of life for healthy citizens through the consolidation of efforts of state bodies authorities in the sphere of health protection, doctors, and pharmaceutical supply systems. Β© 2017, Folium Ltd. All rights reserved
Ways to improve the efficiency of pharmaceutical care in the treatment of tuberculosis
The article is devoted to generalization of the ways to optimize the consumption of antibacterial and anti-tuberculosis drugs in tuberculosis. The effectiveness of pharmaceutical treatment for tuberculosis in legal, organizational, and financial aspects is analyzed. Identified bottlenecks, the removal of which will allow you to optimize medicinal assistance to persons suffering from tuberculosis, to improve the effectiveness of spending financial means of the Federal budget and the quality of life for healthy citizens through the consolidation of efforts of state bodies authorities in the sphere of health protection, doctors, and pharmaceutical supply systems. Β© 2017, Folium Ltd. All rights reserved